首页 | 本学科首页   官方微博 | 高级检索  
检索        

CD105 、MMP-2 和MMP-9 在骨巨细胞瘤中的表达及意义
引用本文:蔡颖,冯一中,张熔熔,施启丰,唐威.CD105 、MMP-2 和MMP-9 在骨巨细胞瘤中的表达及意义[J].肿瘤防治研究,2007,34(7):490-492,546.
作者姓名:蔡颖  冯一中  张熔熔  施启丰  唐威
作者单位:1. 214002,江苏无锡市第二人民医院病理科
2. 苏州大学附属第二医院病理科
3. 无锡市锡山人民医院病理科
摘    要: 目的 探讨骨巨细胞瘤中CD105、MMP-2和MMP-9的表达及与肿瘤复发的关系。方法 应用免疫组化SP法检测CD105、MMP-2和MMP-9在38例骨巨细胞瘤中的表达,分析它们与肿瘤临床病理参数及术后复发的关系。结果 (1)CD105标记的肿瘤内MVD均值为9.70±2.34,浸润型肿瘤的MVD值明显高于静止型(P〈0.05),复发组MVD值显著高于未复发组(P〈0.01),而与组织学分级无关(P〉0.05)。(2)MMP-2的阳性表达率为47.37%,其表达与复发有关(P〈(1.05),而与组织学分级、X线分型无关(P〉0.05)。(3)MMP-9的阳性表达率为6(1.53%,与组织学分级无关(P〉(1.05),与X线分型和复发有关(P〈0.01)。(4)MMP-2、MMP-9阳性组的MVD值分别高于相应的阴性组(P〈0.01)。结论 CD105标记的MVD值和MMP-2、MMP-9过表达可作为预测骨巨细胞瘤复发的客观依据。MMP2、MMP-9过表达与肿瘤内新生血管的形成有关。

关 键 词:骨巨细胞瘤  CD105  基质金属蛋白酶类  免疫组织化学
文章编号:1000-8578(2007)07-0490-03
收稿时间:2006-6-16
修稿时间:2006-06-162006-07-31

Expression and Significance of CD105 ,MMP-2 and MMP-9 in Giant Cell Tumor of Bone
CAI Ying,FENG Yi-zhong,ZHANG Rong-rong,SHI Qi-feng,TANG Wei.Expression and Significance of CD105 ,MMP-2 and MMP-9 in Giant Cell Tumor of Bone[J].Cancer Research on Prevention and Treatment,2007,34(7):490-492,546.
Authors:CAI Ying  FENG Yi-zhong  ZHANG Rong-rong  SHI Qi-feng  TANG Wei
Institution:1. Department of Pathology , Wuxi the Second People’s Hospital , Wuxi 214002 , China; 2. Department of Pathology , the Second Hospital Affiliated of Soochow University ;3. Department of Pathology , Xishan People’s Hospital
Abstract:Objective  To study the expression level of CD105 ,MMP-2 and MMP-9 in giant cell tumor of bone and to detect the correlation between their expression levels and tumor recurrence. Methods  The expressions of CD105 , MMP-2 and MMP-9 in 38 cases of giant cell tumor of bone were studied by using SP immunohistochemical method. Their relationship with clinicopathological features and tumor recurrence after operation was analysed too. Results  (1) The average value of MVD in tumor was 9. 70 ±2. 34 , which was much higher in aggressive type cases than in quiescent type ( P < 0. 05) . Recurrent cases had higher MVD value than cases without recurrence( P < 0. 01) , yet was not associated with histological grade ( P > 0. 05) . (2) The expression ratio of MMP-2 was 47. 37 %. Recurrent cases had higher positive rate than cases without recurrence ( P <0. 05) . No distinct difference of the expression ratio was found among cases of different histological grade andradiological type ( P > 0. 05) . (3) Positive rate of MMP-9 was 60. 53 %. No distinct difference of the expression level of MMP-9 was found among cases of different histological grade ( P > 0. 05) . Tumors of aggressive type and active type had higher positive rate than quiescent type cases ( P < 0. 01) ,and recurrent cases had higher positive rate than cases without recurrence ( P < 0. 01) . (4) MMP-2 positive cases had higher MVD than MMP-2 negative cases ( P < 0. 01) ,MMP-9 positive cases had higher MVD than MMP-9 negative cases ( P < 0. 01) .Conclusion  MVD counted with CD105 and overexpression of MMP-2 and MMP-9 could be used as objective prognostic indicators of tumor recurrence. Angiogenesis in tumor might be promoted by the overexpression of MMP-2 and MMP-9.
Keywords:CD105
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号